Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-term follow-up for hip prosthetic joint infections at University Hospitals Leuven

Official title: Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven

Run by Universitaire Ziekenhuizen KU Leuven · NCT05000723 · Data updated 2026-11-12

This study looks at patients with hip joint infections after surgery to see how well different treatments work over time.

More Prosthetic Joint Infection trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven)
StatusRecruiting
StartedJuly 14, 2022
Main results expectedDecember 2099
Study endsDecember 2099
Registry record updatedMarch 16, 2026
Trial IDNCT05000723 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with hip prosthetic joint infection based on established criteria.

Probably not a fit

Patients with infections of the native hip joint or those preferring treatment outside of University Hospitals Leuven may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with prosthetic joint infection (PJI) of the hip, a serious complication following total hip replacement surgery. The study aims to collect and analyze data on these patients to better understand treatment outcomes and success rates based on historical results. Given the complexities and variations in PJI cases, the research will provide insights into effective multidisciplinary and patient-tailored treatment approaches. The study is conducted at University Hospitals Leuven, where physicians have extensive experience in managing this condition.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients suffering from hip prosthetic joint infections.

How similar studies have gone: While there are challenges in conducting randomized controlled trials for PJI, the collection of observational data has shown promise in informing treatment approaches in similar contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* patients diagnosed with PJI of the hip based on EBJIS 2021 criteria

Exclusion Criteria:

* Patients unable to provide written informed consent
* Patients who prefer treatment outside of University Hospitals Leuven
* Patients with infections of the native hip joint
* Patients with fracture-related infections (FRI)
* Patients with uncertain diagnosis of PJI according to the 2021 EBJIS criteria
* Patient younger than 18 years

Where it's running

  • University Hospitals Leuven - Gasthuisberg
    Leuven, Belgium
    Recruiting

Study contacts

  • Principal investigator: Georges Vles, Md, PhD — Universitaire Ziekenhuizen KU Leuven
  • Study coordinator: Georges Vles, MD, PhD
  • Email: georges.vles@uzleuven.be
  • Phone: 016340888

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.